Status:
UNKNOWN
Impact of Adding Midzolam to Bupavicaine 0.5% in Regional Spinal Anaesthesia on Maternal Middle Cerebral Artery Velocimetry in Parturients With Severer Preeclampsia
Lead Sponsor:
Minia University
Conditions:
Midazolam in Preeclamptic Patients
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
Trial to use GABA mimetic action of midazolam to ameliorate the severe preeclampsia induced neuronal excitotoxicity using middle cerebral artery transcranial doppler resisitive vasculer indices to eva...
Eligibility Criteria
Inclusion
- All parturients with severe preeclampsia for urgent C.S
Exclusion
- Ladies refusal to participate. Refusal to have spinal anesthsia
Key Trial Info
Start Date :
January 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 5 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04283110
Start Date
January 12 2019
End Date
April 5 2020
Last Update
February 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Elminia university
Cairo, Egypt, 61511